Mamas A. Mamas ✓

@mmamas1973 · United Kingdom · joined 15 Feb 2017

Professor of Cardiology @KeeleUniversity. Research: CV Epidemiology. Associate Editor @CircIntv. Senior clinical editor @TCTMD. @BCIS_uk audit lead.

81 448Followers

41 791Following

88 088Posts total

140.1KViews on collected posts

Against accounts of the same size

4 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views4 031this account1 540median for 10K–100K

Reach, %4.95%this account4.74%median for 10K–100K

Engagement, %0.68%this account1.87%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	4 031	1 540	2.62×
Reach (views ÷ followers)	4.95%	4.74%	1.04×
Engagement rate	0.68%	1.87%	0.37×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

4.3K15 Mar

2.8K

2.5K

2.8K

2.3K

771

2.7K

2.7K

3.4K

3K

2.4K3 Sep

2.9K

6.2K4 Sep

5.2K

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.98%15 Mar

1.45%

1.47%

1.63%

1.66%

1.17%

1.72%

1.72%

1.45%

1.89%

0.25%3 Sep

0.83%

0.54%4 Sep

1.16%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.87%.

What the audience does

Likes76.9%1 263 in total

Reposts7.8%128 in total

Replies8.3%137 in total

Quotes1.2%20 in total

Bookmarks5.7%94 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Our analysis from NHANES suggested that LPa only had a prognostic impact in those at high cv risk ➡️ https://t.co/50Z2I03ahv Reducing LPa in those with well controlled RF at low cv risk probably wont represent a meaningful tx strategy Will be interesting to see whether there is 5.2K views · 47 likes · 11 reposts · 0 replies 04 Sep 2026 Will be interesting to see data from the ≥90 mg/dL Subgroup If thats also negative will need a major rethink re LPa story 6.2K views · 25 likes · 2 reposts · 5 replies 04 Sep 2026 TARGET-CTCA: When MI’s Already Ruled Out in Chest Pain, Imaging Doesn’t Add Much https://t.co/diJL2dVFpJ 2.9K views · 13 likes · 10 reposts · 1 replies 03 Sep 2026 ACASA-TAVI and NOTION-4 Trials Give Mixed Messages on DOACs After TAVI https://t.co/b9ioa8mLI0 2.4K views · 5 likes · 1 reposts · 0 replies 03 Sep 2026 10. Most importantly have fun and enjoy what your doing. I have enjoyed working with some of the brightest most diverse minds across the globe. I have enjoyed discussing methodology, developing clinical questions and most importantly watching people flourish to be independent 3K views · 51 likes · 1 reposts · 5 replies 15 Mar 2025 9. Invest in people. Give people a chance. Some of my very best fellows have had to fight to get to where they are in their careers often moving countries and sacrificing living with their families. They werent necessarily the strongest people on paper when i met them but were 3.4K views · 45 likes · 3 reposts · 1 replies 15 Mar 2025 8. When you become a group leader- use your privilege. Support younger academics both within / outwith your group. Support women / academics from developing countries where barriers have traditionally been much higher. Being senior author when you have hundreds of papers wont 2.7K views · 43 likes · 3 reposts · 1 replies 15 Mar 2025 7. Not all papers that i have published have made a meaningful contribution to science- But they were meaningful to the person that wrote them Even if you dont think that the paper is great- try your best to improve it and be respectful to the fellow / individual that spent 2.7K views · 43 likes · 2 reposts · 1 replies 15 Mar 2025 @mmamas1973 Congratulations!!! I would not call it "sort of" landmark @mmamas1973 😀. I feel honored to have collaborated with you. Thanks for your sharing your inspiring pearls of wisdom. 771 views · 8 likes · 0 reposts · 1 replies 15 Mar 2025 6. Think about your collaboration network- dont go to the same academics all the time. Try to build networks, be diverse- no one wants to see a MANEL. Give people opportunities -someone who doesnt get invited often to papers will invest a lot of time in your work. 2.3K views · 36 likes · 2 reposts · 1 replies 15 Mar 2025 5. Treat every paper as though you are the senior author in terms of feedback / time investment. Someone has spent several months / years producing this paper. Providing superficial edits is insulting at best- that isnt the way to create meaningful collaborations 2.8K views · 43 likes · 2 reposts · 1 replies 15 Mar 2025 4. Dont be afraid to turn down coauthorship - it may be because you dont think analysis is robust or you have no expertise in area or you dont have time to meaningfully contribute 2.5K views · 35 likes · 1 reposts · 1 replies 15 Mar 2025 3. Never co-author a manuscript where you dont understand methods. Again i have removed myself from authorship in such situations 2.8K views · 36 likes · 2 reposts · 2 replies 15 Mar 2025 2. Like everything in life- treat others as you would want to be treated yourself. People that do the work should be recognised. If they lead the manuscript they should be first author. Anything else is dishonest. Only take senior authorship if you have led manuscript / ideas, 4.3K views · 73 likes · 7 reposts · 6 replies 15 Mar 2025 1. After 24 years i have achieved a sort of landmark- i have published my 1000th peer reviewed publication ➡️ https://t.co/JqW6CB9pjf My first paper was around spinal cord injury, and for the 1000th paper It is fitting that it was: Percutaneous Coronary Intervention in the UK: 96.1K views · 760 likes · 81 reposts · 111 replies 15 Mar 2025

Similar accounts